Polyphenol-rich Haskap berries (Haskap) have untapped therapeutic potential to improve human health, and agricultural producers in northern U.S. states are poised to increase production if consumer demand increases. A critical knowledge gap is that little is known about the interactions between gut microbes and Haskap polyphenols to produce bioactive metabolites linked to downstream health impacts. Additionally, little is known about which Haskap varieties and harvest timing yield the greatest bioactive potential. This study aims to address these gaps by investigating the interaction of bioactive components in Haskap with gut microbiota and the resultant gut and serum metabolites, inflammation, and metabolic health, and then couple this with analysis of berries from different Haskap varieties and harvest times.
The long-term goal of this project is to form a partnership linking the health impacts of Haskap varieties and management practices that maximize health-promoting compounds to benefit both consumers and producers. Specific objectives of this study are to determine 1) the impact of Haskap on the gut microbiome and metabolome, 2) how gut microbiome composition and production of bioactive metabolites from Haskap impacts health and inflammation biomarkers, and 3) which Haskap varieties and growing practices increase production of health-promoting compounds. To accomplish this, a four-armed, randomized, triple-blind, placebo controlled clinical trial of Haskap versus placebo for two separate groups with distinctly low and high metabolic syndrome status will be completed. Participants will be assessed for health biometrics, fat oxidation, gut microbiome composition, inflammation, and both the gut and serum metabolome before and after 8 weeks of intervention. Haskap fruit from twenty varieties will primarily come from the randomized block design field trial and fruit will be harvested at four stages of fruit maturity, then analyzed for polyphenol content. This part of the study will be replicated over three growing seasons.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
120
A smoothie blend of berries and water
A smoothie with no polyphenolic content and matched in carbohydrate composition to the experimental haskap smoothie
Montana State University
Bozeman, Montana, United States
RECRUITING16 subunit ribosomal ribonucleic acid (16S rRNA) gut microbial composition
fecal microbial composition
Time frame: 8 weeks
Inflammation (pg/mL)
Serum interleukin (IL) IL-1B, IL-6, IL-10, IL-17, IL-23, tumor necrosis factor alpha (TNF-alpha), granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon gamma (IFN-gamma)
Time frame: 8 weeks
Lipid Panel (mg/dL)
Serum triglycerides (TG), low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, total cholesterol (CHOL), glucose (GLU)
Time frame: 8 weeks
F2 isoprostanes
urine
Time frame: 8 weeks
Untargeted metabolomic analysis
Serum metabolome
Time frame: 8 weeks
Untargeted metabolomic analysis
Fecal metabolome
Time frame: 8 weeks
Exercise Induced Fat Oxidation
Measurement in g/min of fat being utilized during exercise at 40-60% of the participants estimated VO2max
Time frame: 8 weeks
Acute Diet
24-hour dietary recall using the Automated Self-Administered 24-hour Dietary. Assessment Tool (ASA24). Outcome is macronutrient and micronutrient composition of food entry.
Time frame: 8 weeks
Habitual Diet
Habitual diet recall using Dietary History Questionnaire (DHQ) III (1 year recall). Outcome measures are healthy eating index (HEI) scores which include nine components based on adequacy (total fruit, whole fruit, total vegetables, greens and beans, whole grains, dairy, total protein foods, seafood and plant proteins, fatty acids) and four components based on moderation (refined grains, so-dium, added sugars, saturated fats). Each component is ranked 1-10 in order of increasing health. Total HEI score is reported as the sum of all components (100 possible points) with more points indicating increased health of diet.
Time frame: Baseline
Anthropometric Assessments
waist circumference (cm)
Time frame: 8 weeks
Anthropometric Assessments
visceral adipose (L)
Time frame: 8 weeks
Anthropometric Assessments
BMI (kg/m2)
Time frame: 8 weeks
Anthropometric Assessments
fat free mass (%)
Time frame: 8 weeks
Blood pressure
SBP/DBP (mmHG)
Time frame: 8 weeks
Estimated VO2 max
Estimation of participants VO2 max (ml/k/min) from a Fatmax test
Time frame: 0 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.